UBS Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-148,500
Closed -$3.82M 7679
2018
Q4
$3.82M Buy
+148,500
New +$5.14M ﹤0.01% 2413

Other funds holding ACHC

UBS Group's ACHC Position: Q2 2026 in Review

UBS Group increased its Acadia Healthcare (ACHC) stake by 43% in Q2 2026, buying an estimated $31.1M and bringing the position to 4,044,500 shares worth $119M. The position accounts for 0.02% of the portfolio, ranked #1002.

UBS Group first reported a position in ACHC in Q4 2014 and has held it in 47 quarters since. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • UBS Group held 4,044,500 shares of Acadia Healthcare worth $119M as of Q2 2026.
  • UBS Group bought 1,210,638 Acadia Healthcare shares in Q2 2026, an estimated $31.1M.
  • Acadia Healthcare made up 0.02% of UBS Group's portfolio in Q2 2026, its #1002 holding.
  • UBS Group first reported a position in Acadia Healthcare in Q4 2014 and has held it in 47 quarters since.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.